FAQ #1 –
Why is circulating tumor DNA (ctDNA) important?
Circulating tumor DNA (ctDNA) is essential as a non-invasive “liquid biopsy” to detect, monitor, and treat cancer. By analyzing small fragments of tumor DNA in the blood, it enables real-time monitoring of tumor burden, early detection of relapse, identification of resistance mutations, and personalized treatment adjustments, often outperforming traditional imaging
FAQ #2 –
What is multi omics technology?
Multi-omics technology is an integrative, high-throughput approach that combines data from multiple biological layers—genomics, transcriptomics, epigenomics, proteomics, and metabolomics—to provide a comprehensive, holistic understanding of molecular mechanisms, disease pathology
FAQ #3 –
What is the role of Ai in NGS testing?
AI in Next-Generation Sequencing (NGS) accelerates and improves the accuracy of genomic analysis by automating complex, data-intensive tasks across the entire workflow, from laboratory quality control (QC) to clinical diagnosis
FAQ #4 –
What samples types can 1Cell.Ai perform NGS tests on?
1Cell.Ai lab has the capability to test Whole blood, Bone marrow aspirate,Tissue,Ascitic fluid & CSF samples
FAQ #5 –
Is your lab facility certified to perform quality NGS testing?
The state of the art lab facility at Pune is NABL & CAP accredited with qualified genomic specialists which ensure best process for NGS testing